BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 30776091)

  • 1. A proposal for updating the staging of endometrial cancer.
    Maheshwari A; Gupta S; Prat J
    Int J Gynaecol Obstet; 2019 May; 145(2):245-252. PubMed ID: 30776091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
    Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
    Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer.
    Kobayashi-Kato M; Fujii E; Asami Y; Ahiko Y; Hiranuma K; Terao Y; Matsumoto K; Ishikawa M; Kohno T; Kato T; Shiraishi K; Yoshida H
    Gynecol Oncol; 2023 Nov; 178():36-43. PubMed ID: 37748269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New staging of endometrial carcinoma - FIGO 2023.
    Hruda M; Sehnal B; Halaška MJ; Drozenová J; Robová H; Pichlík T; Rob L
    Ceska Gynekol; 2024; 89(2):120-127. PubMed ID: 38704224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving into the modern era of molecular classification for endometrial cancer.
    Dagher C; Liu YL; Mueller JJ; Weigelt B
    J Surg Oncol; 2024 Jan; 129(1):120-125. PubMed ID: 38100711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Advances in Endometrial Cancer: Integration of Molecular Classification into Staging for Enhanced Prognostic Accuracy and Implications for Racial Disparities.
    Ogunmuyiwa J; Williams V
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO 2023 endometrial cancer staging system: recommendations for the UK.
    Wong J; Bani-Khalid A; Ganesan R; Rous B; Arora R; Dobbs S; McCluggage WG
    Histopathology; 2024 Jun; 84(7):1242-1243. PubMed ID: 38288633
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective.
    Chandramohan A; Manchanda S; Renganathan R; Popat PB; Shah D; Dhamija E; Sen A
    Indian J Radiol Imaging; 2024 Apr; 34(2):309-323. PubMed ID: 38549900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variations in endometrial cancer: from biological significance to clinical utility.
    Dugo E; Piva F; Giulietti M; Giannella L; Ciavattini A
    Int J Gynecol Cancer; 2024 Apr; ():. PubMed ID: 38677776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the editor-The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?
    Betella I; De Vitis LA; Calidona C; Multinu F; Colombo N
    Int J Gynaecol Obstet; 2024 Jan; 164(1):364-365. PubMed ID: 38055223
    [No Abstract]   [Full Text] [Related]  

  • 12. Endometrial Cancer.
    Lu KH; Broaddus RR
    N Engl J Med; 2020 Nov; 383(21):2053-2064. PubMed ID: 33207095
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
    León-Castillo A; de Boer SM; Powell ME; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Singh N; Pollock PM; Bessette P; Fyles A; Haie-Meder C; Smit VTHBM; Edmondson RJ; Putter H; Kitchener HC; Crosbie EJ; de Bruyn M; Nout RA; Horeweg N; Creutzberg CL; Bosse T;
    J Clin Oncol; 2020 Oct; 38(29):3388-3397. PubMed ID: 32749941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment for endometrial cancer.
    Emons G; Vordermark D
    Curr Opin Oncol; 2019 Sep; 31(5):404-410. PubMed ID: 31233482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current recommendations and recent progress in endometrial cancer.
    Brooks RA; Fleming GF; Lastra RR; Lee NK; Moroney JW; Son CH; Tatebe K; Veneris JL
    CA Cancer J Clin; 2019 Jul; 69(4):258-279. PubMed ID: 31074865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial Cancer: An Overview of Pathophysiology, Management, and Care.
    Passarello K; Kurian S; Villanueva V
    Semin Oncol Nurs; 2019 Apr; 35(2):157-165. PubMed ID: 30867105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiology-pathology correlation of endometrial carcinoma assessment on magnetic resonance imaging.
    Dokter E; Anderson L; Cho SM; Cohen-Hallaleh V; Lam KM; Saidi SA; Kitzing YX
    Insights Imaging; 2022 Apr; 13(1):80. PubMed ID: 35467253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases.
    Zhang Z; Gao P; Bao Z; Zeng L; Yao J; Chai D; Li T
    Front Oncol; 2021; 11():732782. PubMed ID: 34926250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma.
    Bandala-Jacques A; Cantú-de-León D; Pérez-Montiel D; Salcedo-Hernández RA; Prada D; González-Enciso A; Gonzalez-Valdés A; Barquet-Muñoz SA
    World J Surg Oncol; 2020 Oct; 18(1):284. PubMed ID: 33126895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
    Barquet-Muñoz SA; Cantú-de-León D; Bandala-Jacques A; González-Enciso A; Isla-Ortiz D; Prada D; Herrera LA; Salcedo-Hernández RA
    World J Surg Oncol; 2020 May; 18(1):101. PubMed ID: 32438919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.